HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $246,000 | -94.7% | 43,000 | -86.4% | 0.00% | -95.7% |
Q2 2020 | $4,636,000 | +20.8% | 315,161 | +93.0% | 0.02% | +76.9% |
Q4 2019 | $3,839,000 | +610.9% | 163,328 | +462.5% | 0.01% | +550.0% |
Q2 2019 | $540,000 | -49.8% | 29,036 | -34.1% | 0.00% | -50.0% |
Q1 2019 | $1,076,000 | -31.8% | 44,040 | -27.5% | 0.00% | -42.9% |
Q4 2018 | $1,577,000 | +120.3% | 60,782 | +229.8% | 0.01% | +133.3% |
Q2 2018 | $716,000 | – | 18,432 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TANG KEVIN C | 760 | $1,900 | 100.00% |
Velan Capital Investment Management LP | 2,500,000 | $6,250,000 | 5.52% |
GREAT POINT PARTNERS LLC | 6,360,161 | $15,900,403 | 3.12% |
Cheyne Capital Management (UK) LLP | 318,008 | $795,020 | 1.39% |
TANG CAPITAL MANAGEMENT LLC | 3,755,934 | $9,389,835 | 1.36% |
Rubric Capital Management LP | 11,750,000 | $29,375,000 | 1.28% |
Orchard Capital Management, LLC | 1,391,080 | $3,477,700 | 1.17% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 267,028 | $667,570 | 0.81% |
CM Management, LLC | 250,000 | $625 | 0.75% |
Tejara Capital Ltd | 493,619 | $1,234,048 | 0.71% |